STEPHEN A SHERWIN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for STEPHEN A SHERWIN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of STEPHEN A SHERWIN. STEPHEN A SHERWIN is a Chairman & C.E.O. in CELL GENESYS INC ($CEGE) and a Chairman & Chief Exec. Officer in CELL GENESYS INC ($CEGE) and a Chairman and CEO in CELL GENESYS INC ($CEGE) and a Director in VICAL INC ($VICL) and a Director in BIOGEN INC. ($IDPH) and a Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and a Director in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in ADURO BIOTECH, INC. ($ADRO) and a Director in Verastem, Inc. ($VSTM) and a Director in Neon Therapeutics, Inc. ($NTGN).

Address: C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO 94080 CA

Companies in which STEPHEN A SHERWIN is an Insider

BIOGEN INC.

Trading Symbol: IDPH
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 16,328 shares
Latest Transaction: Jun 05 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Brickell Biotech, Inc.

Trading Symbol: VICL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 22,003 shares
Current Value: $46,866
Latest Transaction: May 26 2015
$VICL Market Capitalization: $24.86M
$VICL Previous Close: $2.13

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CELL GENESYS INC

Trading Symbol: CEGE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Chairman and CEO, Chairman & C.E.O., Chairman & Chief Exec. Officer
Holdings: 0 shares
Latest Transaction: Oct 15 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CHINOOK THERAPEUTICS, INC.

Trading Symbol: ADRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 28 2020
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Neon Therapeutics, Inc.

Trading Symbol: NTGN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Latest Transaction: May 06 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEUROCRINE BIOSCIENCES INC

Trading Symbol: NBIX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 29,861 shares
Current Value: $1,301,940
Latest Transaction: May 21 2020
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

RIGEL PHARMACEUTICALS INC

Trading Symbol: RIGL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 12 2016
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Verastem, Inc.

Trading Symbol: VSTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2015
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of STEPHEN A SHERWIN

Sentiment: All, IDPH, VICL, CEGE, ADRO, NTGN, NBIX, RIGL, VSTM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 05 2020IDPHBIOGEN INC.SHERWIN STEPHEN ADirectorGrantA0.00890016,32815.4 K to 16.3 K (+5.76 %)
May 28 2020ADROADURO BIOTECH, INC ...SHERWIN STEPHEN ADirectorOption ExerciseA3.0030,00090,00030,000
May 21 2020NBIXNEUROCRINE BIOSCIE ...SHERWIN STEPHEN ADirectorOption ExerciseA119.936,018721,7396,018
May 06 2020NTGNNeon Therapeutics, ...SHERWIN STEPHEN ADirectorOption ExerciseD2.655,00013,2500
May 06 2020NTGNNeon Therapeutics, ...SHERWIN STEPHEN ADirectorOption ExerciseD4.6418,50085,8400
May 06 2020NTGNNeon Therapeutics, ...SHERWIN STEPHEN ADirectorOption ExerciseD16.0014,000224,0000
May 06 2020NTGNNeon Therapeutics, ...SHERWIN STEPHEN ADirectorSellD0.0045,0000045 K to 0 (-100.00 %)

View all STEPHEN A SHERWIN insider transactions.